COMPARISON BETWEEN TWO DRUGS TO CHECK THE EFFECTIVENESS ON HEMODYNAMIC PARAMETERS
Phase 3
- Conditions
- Health Condition 1: null- ATTENUATION DURING ANESTHESIA IN LAPROSCOPIC CHOLECYSTECTOMY
- Registration Number
- CTRI/2018/07/014901
- Lead Sponsor
- SSG HOSPITAL VADODARA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1Age Group 18 -65years
2ASA status I & II
3Male / female
Patients posted for laparoscopic cholecystectomy
Exclusion Criteria
•Anticipated difficult airway and obesity
•Patient having allergy to study drug
•Patient with systemic diseases like severe hypertension, cardiovascular, respiratory, neurological, psychological, hepatic, renal disease (diagnosed by clinical judgments and investigations) and on medication of above mentioned diseases
•Patients with heart rate <60 beats/mi
•Pregnant or lactating females
•Patients who refuse to give consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It will be expected that both drugs will be effectively able to attenuate hemodynamic stress response during anaesthesia for laparoscopic cholecystectomy with CO2 pneumoperitoneumTimepoint: 1.Baseline <br/ ><br>2.Before and after infusion <br/ ><br>3.Before and after intubation <br/ ><br>4.Before and after Pneumoperitoneum <br/ ><br>5.After release of Pneumoperitoneum <br/ ><br>6.After Extubation <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1Amount of induction agent used <br/ ><br>2Post-operative sedation â??Ramsay sedation score <br/ ><br>â?¢Post-operative Analgesia-Visual analogue scaleTimepoint: 1min,15min,30min,60min,120min